Health Ministry denies detection of XE variant in India Roshni Dhar8 April 2022 12:00 PM ISTIn response to the media reports that claimed that a case of the new mutant was reported in Mumbai, the Union Health Ministry said that present...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
GST for COVID drugs pegged at 5 percent, says Govt Ruchika Sharma5 April 2022 10:30 AM ISTNew Delhi: COVID-19 medicines and instruments are being sold at a GST rate of five per cent while other medicines are sold at a GST rate between five...
ED files charge sheet in Remdesivir black marketing case MD Bureau5 April 2022 9:00 AM ISTNew Delhi: The Enforcement Directorate (ED) on Monday said that they have filed a prosecution complaint (charge sheet) against Rahul Bardhan, Biswajit...
Covid-19: WHO suspends UN supply of Covaxin over manufacturing deficiencies Roshni Dhar4 April 2022 4:52 PM ISTThe Bharat Biotech's COVID-19 vaccine, COVAXIN has been suspended by World Health Organization (WHO) from its Covax facility, announced the UN health...
Roche gets USFDA priority review for Actemra to treat Covid-19 Ruchika Sharma4 April 2022 2:32 PM ISTBasel: Roche today announced that the U.S. Food and Drug Administration (USFDA) has accepted the company's supplemental Biologics License Application...
No impact on Covaxin safety, clarifies Bharat Biotech after WHO suspension Ruchika Sharma4 April 2022 1:06 PM IST"It does not indicate a change in risk-benefit ratio (for Covaxin) and the data, available to WHO, indicates the vaccine is effective and no safety...
Govt panel recommends SII Covovax inclusion in national vaccination programme for 12 and above Ruchika Sharma4 April 2022 12:06 PM ISTSingh had stated that the Pune-based firm wanted to provide Covovax to private hospitals at Rs 900 per dose plus GST and was waiting for directions to...
COVID vaccine: Russia registers nasal version of Sputnik V Ruchika Sharma3 April 2022 11:30 AM ISTThe nasal vaccine will be efficient against the new Omicron coronavirus strain, Gintsburg said.
Pfizer COVID vaccine cut Omicron hospitalisations by 68 percent in kids aged 5-11 MD Bureau3 April 2022 10:30 AM ISTNew York: Vaccination of 5 to 11-year-olds reduced hospitalisations with Covid-19 by more than two thirds during the Omicron surge and also protected...
Novavax seeks conditional marketing nod for Nuvaxovid in adolescents Ruchika Sharma3 April 2022 9:00 AM ISTGaithersburg: Novavax, Inc. has announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid COVID-19...
COVID-19: Bharat Biotech temporarily slows down Covaxin production Ruchika Sharma2 April 2022 10:30 AM IST"For the coming period, the company will focus on pending facility maintenance, process, and facility optimisation activities," Bharat Biotech said in...
